Balance at December 31, 2019 110,619,678 $ 11 $ 889,955 $ (946,884) $ (218) $ (57,136) $ — $ (57,136) Stock-based compensation expense — — 2,725 — — 2,725 — 2,725 Shares issued in connection with employee stock plans, net of shares withheld for employee taxes 665,055 — (568) — — (568) — (568) Assignment of OpenNMS (see Note 19) — — (529) — — (529) 503 (26) Other comprehensive income — — — — 50 50 1 51 Net loss — — — (56,326) — (56,326) (120) (56,446) Balance at December 31, 2020 111,284,733 11 891,583 (1,003,210) (168) (111,784) 384 (111,400) Modified retrospective adjustment on adoption of ASU 2020-06 (Note 2) — — (14,318) 8,572 — (5,746) — (5,746) Stock-based compensation expense — — 4,005 — — 4,005 — 4,005 Shares issued in connection with employee stock plans, net of shares withheld for employee taxes 604,541 — 291 — — 291 — 291 Stock issued on Exchange of 2016 Notes 3,615,970 1 10,000 — — 10,001 — 10,001 Purchase of noncontrolling interest — — (456) — — (456) (100) (556) Other comprehensive loss — — — — (44) (44) — (44) Net loss — — — (58,259) — (58,259) (284) (58,543) Balance at December 31, 2021 115,505,244 $ 12 $ 891,105 $ (1,052,897) $ (212) $ (161,992) $ — $ (161,992) Common Stock Additional Paid-In Capital Accumulated Deficit Accumulated Other Comprehensive Loss Total NantHealth Stockholders' Deficit Noncontrolling interests Total Stockholders' Deficit Shares Amount The accompanying notes are an integral part of these Consolidated Financial Statements. NantHealth, Inc. Consolidated Statements of Stockholders’ Deficit (Dollars in thousands) - 99 -
RkJQdWJsaXNoZXIy NTIzOTM0